Classification Criteria

  • Chiara Baldini
  • Rosaria Talarico
  • Stefano Bombardieri


Over the past 25 years, several classification criteria sets have been proposed for primary Sjögren’s syndrome (pSS). In this chapter, we describe the different features of these criteria and summarize the debate that has arisen in the scientific community over this period. We devote particular attention to a critical analysis of the American and European consensus group criteria (AECG), which have achieved important consensus in the literature. Proposals for the future are also outlined.


Rose Bengal Salivary Flow Rate Keratoconjunctivitis Sicca Focus Score Sicca Symptom 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



We thank Miss Wendy Doherty and Miss Luisa Marconcini for their valuable contribution in reviewing the text.


  1. 1.
    Nikolov NP, Illei GG. Pathogenesis of Sjögren’s syndrome. Curr Opin Rheumatol. 2009;21(5):465–70.PubMedCrossRefGoogle Scholar
  2. 2.
    Fietta P, Delsante G, Quaini F. Hematologic manifestations of connective autoimmune diseases. Clin Exp Rheumatol. 2009;27(1):140–54.PubMedGoogle Scholar
  3. 3.
    Voulgarelis M, Tzioufas AG, Moutsopoulos HM. Mortality in Sjögren’s syndrome. Clin Exp Rheumatol. 2008;26(5 Suppl 51):S66–71.PubMedGoogle Scholar
  4. 4.
    Theander E, Jacobsson LT. Relationship of Sjögren’s syndrome to other connective tissue and autoimmune disorders. Rheum Dis Clin North Am. 2008;34(4):935–47, viii–ix.PubMedCrossRefGoogle Scholar
  5. 5.
    Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carson SE, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Iorgulescu G. Saliva between normal and pathological. Important factors in determining systemic and oral health. J Med Life. 2009;2(3):303–7.PubMedGoogle Scholar
  7. 7.
    Kikuchi M, Inagaki T, Ogawa K, Banno S, Matsumoto Y, Ueda R, et al. Histopathological investigation of salivary glands in the asymptomatic elderly. Arch Gerontol Geriatr. 2004;38(2):131–8.PubMedCrossRefGoogle Scholar
  8. 8.
    Manthorpe R, Oxholm P, Prause JU, Schiodt M. The Copenhagen criteria for Sjögren’s syndrome. Scand J Rheumatol. 1986;61:19–21.Google Scholar
  9. 9.
    Homma M, Tojo T, Akizuki M, Yamagata H. Criteria for Sjögren’s syndrome in Japan. Scand J Rheumatol. 1986;61:26–7.Google Scholar
  10. 10.
    Skopouli FN, Drosos AA, Papaioannou T, Moutsopoulos HM. Preliminary diagnostic criteria for Sjögren’s syndrome. Scand J Rheumatol. 1986;61:22–5.Google Scholar
  11. 11.
    Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV. Sjögren’s syndrome. Proposed criteria for classification. Arthritis Rheum. 1986;29(5):577–85.PubMedCrossRefGoogle Scholar
  12. 12.
    Daniels TE, Silverman S, Michalski JP, Greenspan JS, Sylvester RA, Talal N. The oral component of Sjögren’s syndrome. Oral Surg Oral Med Oral Pathol. 1975;39:875–85.PubMedCrossRefGoogle Scholar
  13. 13.
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The 1987 revised American association criteria for classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.PubMedCrossRefGoogle Scholar
  14. 14.
    Daniels TE. Labial salivary gland biopsy in Sjögren’s syndrome: assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum. 1984;27:147–56.PubMedCrossRefGoogle Scholar
  15. 15.
    Fox RI, Saito I. Criteria for diagnosis of Sjögren’s syndrome. Rheumatol Dis North Am. 1994;20(2):391–407.Google Scholar
  16. 16.
    Shah F, Rapini RP, Arnett FC, Warner NB, Smith CA. Association of labial salivary gland histopathology with clinical and serologic features of connective tissue diseases. Arthritis Rheum. 1990;33:1682–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Atkinson JC, Travis WD, Slocum L, Ebbs WL, Fox PC. Serum anti-SS-B/La and IgA rheumatoid factor are markers of salivary gland disease activity in primary Sjögren’s syndrome. Arthritis Rheum. 1992;35:1368–72.PubMedGoogle Scholar
  18. 18.
    Daniels TE, Witcher JP. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren’s syndrome. Arthritis Rheum. 1994;6:869–77.CrossRefGoogle Scholar
  19. 19.
    Prause JU, Manthorpe R, Oxholm P, Schiødt M. Definition and criteria for Sjögren’s syndrome used by the contributors to the First International Seminar on Sjögren’s syndrome – 1986. Scand J Rheumatol Suppl. 1986;61:17–8.PubMedGoogle Scholar
  20. 20.
    Workshop on diagnostic criteria for Sjögren’s syndrome: I. Questionnaires for dry eye and dry mouth. II Manual of methods and procedures. Clin Exp Rheumatol. 1989;7:212–19.Google Scholar
  21. 21.
    Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren’s syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 1993;36(3):340–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli R, Hatron PY, et al. Assessment of the European classification criteria for Sjögren’s syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren’s Syndrome. Ann Rheum Dis. 1996;55(2):116–21.PubMedCrossRefGoogle Scholar
  23. 23.
    Fox RI. Fifth international symposium on Sjögren’s syndrome. Arthritis Rheum. 1996;39(2):195–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Ramos-Casals M, Garcia Carrasco M, Cervera R, Rosas J, Trejo O, de la Red G, et al. Hepatitis C virus infection mimicking primary Sjögren’s syndrome. A clinical and immunologic description of 35 cases. Medicine (Baltimore). 2001;80:1–8.CrossRefGoogle Scholar
  25. 25.
    Novljan MP, Rozman B, Jerse M, Rotar Z, Kveder T, Tomsic M. Comparison of the different classification criteria sets for primary Sjögren’s syndrome. Scand J Rheumatol. 2006;35:463–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Langegger C, Wenger M, Duftner C, Dejaco C, Baldissera I, Moncayo R, et al. Use of the European preliminary criteria, the Breiman classification tree and the American–European criteria for diagnosis of primary Sjögren’s Syndrome in daily practice: a retrospective analysis. Rheumatol Int. 2007;27(8):699–702.PubMedCrossRefGoogle Scholar
  27. 27.
    Binard A, Devauchelle-Pensec V, Fautrel B, Jousse S, Youinou P, Saraux A. Epidemiology of Sjögren’s syndrome: where are we now? Clin Exp Rheumatol. 2007;25(1):1–4.PubMedGoogle Scholar
  28. 28.
    Birlik M, Akar S, Gurler O, Sari I, Birlik B, Sarioglu S, et al. Prevalence of primary Sjögren’s syndrome in Turkey: a population-based epidemiological study. Int J Clin Pract. 2009;63(6):954–61.PubMedCrossRefGoogle Scholar
  29. 29.
    Haugen AJ, Peen E, Hultén B, Johannessen AC, Brun JG, Halse AK, et al. Estimation of the prevalence of primary Sjögren’s syndrome in two age-different community-based populations using two sets of classification criteria: the Hordaland Health Study. Scand J Rheumatol. 2008;37(1):30–4.PubMedCrossRefGoogle Scholar
  30. 30.
    Kabasakal Y, Kitapcioglu G, Turk T, Oder G, Durusoy R, Mete N, et al. The prevalence of Sjögren’s syndrome in adult women. Scand J Rheumatol. 2006;35(5):379–83.PubMedCrossRefGoogle Scholar
  31. 31.
    Bjerrum KB. Keratoconjunctivitis sicca and primary Sjögren’s syndrome in a Danish population aged 30–60 years. Acta Ophthalmol Scand. 1997;75:281–6.PubMedCrossRefGoogle Scholar
  32. 32.
    Zhang NZ, Shi CS, Yao QP, Pan GX, Wang LL, Wen ZX, et al. Prevalence of primary Sjögren’s syndrome in China. J Rheumatol. 1995;22(4):659–61.PubMedGoogle Scholar
  33. 33.
    Alamanos Y, Tsifetaki N, Voulgari PV, Venetsanopoulo AI, Siozos C, Drosos AA. Epidemiology of primary Sjögren’s syndrome in north-west Greece, 1982–2003. Rheumatology. 2006;45:187–91.PubMedCrossRefGoogle Scholar
  34. 34.
    Trontzas PI, Andrianakos AA. Sjögren’s syndrome: a population-based study of prevalence in Greece: The ESORDIG study. Ann Rheum Dis. 2005;64:1240–1.PubMedCrossRefGoogle Scholar
  35. 35.
    Bowman SJ, Ibrahim GH, Holmes G, Hamburger J, Ainsworth JR. Estimating the prevalence among Caucasian women of primary Sjögren’s syndrome in two general practices in Birmingham, UK. Scand J Rheumatol. 2004;33:39–43.PubMedCrossRefGoogle Scholar
  36. 36.
    Tomsic M, Logar D, Grmek M, Perkovic T, Kveder T. Prevalence of Sjögren’s syndrome in Slovenia. Rheumatology. 1999;38:164–70.PubMedCrossRefGoogle Scholar
  37. 37.
    Thomas E, Hay EM, Hajeer A, Silman AJ. Sjögren’s syndrome: a community-based study of prevalence and impact. Br J Rheumatol. 1998;37:1069–76.PubMedCrossRefGoogle Scholar
  38. 38.
    Dafni UG, Tzioufas AG, Staikos P, Skopouli FN, Moutsopoulos MH. Prevalence of primary Sjögren’s syndrome in a closed rural community. Ann Rheum Dis. 1997;56:521–5.PubMedCrossRefGoogle Scholar
  39. 39.
    Jacobsson LT, Axell TE, Hansen BU, Henricsson VJ, Larsson A, Lieberkind K, et al. Dry eyes or mouth – an epidemiological study in Swedish adults, with special reference to primary Sjögren’s syndrome. J Autoimmun. 1989;2(4):521–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Brun JG, Madland TM, Gjesdal CB, Bertelsen LT. Sjögren’s syndrome in an out-patient clinic: classification of patients according to the preliminary European criteria and the proposed modified European criteria. Rheumatology. 2002;41(3):301–4.PubMedCrossRefGoogle Scholar
  41. 41.
    Sánchez-Guerrero J, Pérez-Dosal MR, Cárdenas-Velázquez F, Pérez-Reguera A, Celis-Aguilar E, Soto-Rojas AE, et al. Prevalence of Sjögren’s syndrome in ambulatory patients according to the American-European Consensus Group criteria. Rheumatology. 2005;44(2):235–40.PubMedCrossRefGoogle Scholar
  42. 42.
    Kassan SS, Mutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med. 2004;164:1275–84.PubMedCrossRefGoogle Scholar
  43. 43.
    Ramos Casals M, Tzioufas AG, Font J. Primary Sjögren’s syndrome: new clinical and therapeutic concepts. Ann Rheum Dis. 2005;64:347–54.PubMedCrossRefGoogle Scholar
  44. 44.
    Morbini P, Manzo A, Caporali R, Epis O, Villa C, Tinelli C, et al. Multilevel examination of minor salivary gland biopsy for Sjögren’s syndrome significantly improves diagnostic performance of AECG classification criteria. Arthritis Res Ther. 2005;7(2):R343–8.PubMedCrossRefGoogle Scholar
  45. 45.
    Whitcher JP, Shiboski CH, Shiboski SC, Heidenreich AM, Kitagawa K, Zhang S, et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren’s Syndrome International Registry. Am J Ophthalmol. 2010;149(3):405–15.PubMedCrossRefGoogle Scholar
  46. 46.
    Daniels TE, Criswell LA, Shiboski C, Shiboski S, Lanfranchi H, Dong Y, et al. An early view of the international Sjögren’s syndrome registry. Arthritis Rheum. 2009;61(5):711–4.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  • Chiara Baldini
    • 1
  • Rosaria Talarico
    • 1
  • Stefano Bombardieri
    • 1
  1. 1.Rheumatology Unit, Department of Internal MedicineUniversity of PisaPisaItaly

Personalised recommendations